This bill amends section 893.03 of the Florida Statutes to exclude cannabis and its derivatives from Schedule I of controlled substances when used for bona fide scientific research purposes. The new legal language specifies that cannabis and its derivatives may be utilized for research conducted under applicable federal, state, or institutional regulations. This amendment aims to facilitate scientific studies on cannabis, potentially leading to advancements in medical and therapeutic applications, and reflects a growing recognition of the importance of cannabis research.

In addition to the changes regarding cannabis, the bill introduces new classifications for various psychoactive substances, including synthetic cannabinoids and substituted cathinones, which are now classified as illegal unless part of an FDA-approved pharmaceutical product. The bill provides a comprehensive list of specific compounds, such as AM-2201 and JWH-018, and outlines criteria for what constitutes a synthetic cannabinoid or substituted cathinone. Furthermore, it details classifications for substituted tryptamines and phenylcyclohexylamines, establishing clear definitions and exclusions to enhance public safety by regulating these substances more strictly. The act is set to take effect on October 1, 2025.

Statutes affected:
S 728 Filed: 893.03